Real-world evidence on Kovaltry (81-8973) in children with moderate or severe hemophilia A in Europe: a nested cohort analysis

BACKGROUND: Untreated hemophilia A patients may experience recurrent bleeding events leading to debilitating joint damages. While RCT and pharmacokinetic data support the value of Kovaltry [an unmodified full-length recombinant factor VIII (FVIII) product], real world evidence in children is lacking...

Full description

Saved in:
Bibliographic Details
Published in:Orphanet J Rare Dis
Main Authors: O’Hara, Jamie, Hirst, Ceri, Cabre Marquez, Jose Francisco, Burke, Tom
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Letter to the Editor
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7809751/
https://ncbi.nlm.nih.gov/pubmed/33451335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01676-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items